Newsroom

Newsroom

CEO & Founder of Quadrant, Rich Uhlig, on Leadership

February 2023

Stan Linhorst | Syracuse.com

Quadrant's Clarifi mTBI Concussion Test featured by CNY Central in Syracuse

January 2023

CNY Central

News Channel 9 in Syracuse Features Quadrant's Clarifi mTBI Concussion Test 

November 2022

Local SYR 

Quadrant Biosciences' Chief Technology Officer (CTO) Named to Prestigious List

November 2022

Nick Gianadda, Quadrant's CTO, made the list of the Top 25 Healthcare Technology CTOs of 2022.  

Company News: Quadrant Biosciences announces several promotions and new hires

August 2022

Quadrant Biosciences Inc. recently announced promotions and new hires.

Patent Issued for Multiomic Approach to Autism Spectrum Disorder Diagnosis

February 2022

BioSpace

SU’s wastewater testing has become more valuable in determining COVID transmission

November 2021

The Daily Orange

Marcellus Central School District making it more convenient for students, staff to get tested for COVID

October 2021

Local SYR

Coronavirus company news summary – FDA warns of potential false positives with Abbott tests – Burnet Institute and Doherty Institute develop test to check immunity

September 2021

Medical Device Network

CenterState CEO announces businesses of the year

April 2021

Syracuse.com

Albany International Airport to sell COVID-19 test kits to public

April 2021

Hudson Valley 360

Chancellor Malatras Announces SUNY Surpasses Two Million COVID-19 Tests Conducted for Students, Faculty, and Staff Since the Beginning of the Fall 2020 Semester

April 2021

SUNY.edu

Academic, Commercial Collaboration for Testing

March 2021

The Dark Report

Chancellor Malatras Announces SUNY Campuses Administered Over One Million COVID-19 Tests Since the Start of the 2020-2021 Academic Year

February 2021

SUNY.edu

Upstate Medical building second lab in Buffalo to process more COVID-19 saliva tests

February 2021

Syracuse.com

Chancellor Malatras Announces SUNY Upstate Medical University to Construct a COVID-19 Testing Laboratory at the University at Buffalo to Increase Capacity and Speed Up Analysis as SUNY Campuses Reopen

January 2021

SUNY.edu

MedTech salutes as Project of the Year the saliva swab test for coronavirus

December 2020

Upstate.edu

Airport begins offering COVID saliva test to arriving passengers

December 2020

Times Union

COVID-19 saliva tests are gaining popularity for ease-of-use and reliability

December 2020

Verywell Health

FDA names SUNY Upstate's saliva test as one of the best in detecting COVID-19

December 2020

Local Syr

Governor Cuomo Congratulates SUNY Upstate Medical on #1 FDA Ranking Among COVID-19 Saliva Tests for Detecting Virus In Earliest Stages

December 2020

NYS Governor’s Office

Doug Yeum's most memorable remarks at AWS re:Invent 2020

December 2020

CRN

SUNY Upstate saliva tests to track coronavirus in Albany airport workers and travelers

December 2020

Syracuse.com

Saliva Testing May Help Doctors Diagnose Concussions

November 2020

Science Daily

What is wastewater COVID testing, and how does it work?

November 2020

NNY 360

Cape Vincent native heads Quadrant Biosciences, lab company on cutting edge of COVID research

November 2020

NNY 360

How one university system plans to send home thousands of students for Thanksgiving break

November 2020

ABC News

Study confirms spit testing may help doctors diagnose concussions

November 2020

Health News Digest

Siena College sends wastewater samples to lab for early detection of COVID-19

October 2020

News 10 Albany

In the fight against COVID, colleges look to wastewater

October 2020

WHAM

OraSure's OMNIgene® ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

October 2020

GlobeNewswire

Upstate Medical Gets FDA Approval for Wider Use of its Saliva Swab COVID-19 Test

October 2020

CNY Business Journal

Coronavirus 'smoke detector' launched in Syracuse put brakes on SUNY Oneonta outbreak

September 2020

Syracuse.com

OraSure's ORAcollect RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test

September 2020

Biospace

Governor Cuomo and Chancellor Malatras Announce FDA Approval for COVID-19 Saliva Swab Test

September 2020

NYS Governor’s Office

SUNY may implement biweekly testing to stem campus COVID-19 outbreaks

September 2020

New York Post

Universities search for a blueprint to continue in-person instruction as COVID-19 Pandemic rages

September 2020

CBS 60 Minutes

Saliva test for COVID-19 approved by NY Dept. of Health

September 2020

WHAM

Governor Cuomo announces new testing initiatives to improve COVID-19 detection & control across New York State

August 2020

New York State News

University Scientists Selected to Implement COVID-19 Early Warning System in Upstate New York

August 2020

SUNY ESF

New York State partners with Arcadis to pilot early detection of COVID-19 in wastewater

August 2020

GlobeNewswire

Groundbreaking autism test developed in CNY would diagnose children through saliva

December 2019

CNY Central

Saliva test for autism hits market; Syracuse research could lead to faster help for kids

December 2019

Syracuse

Microbes in Saliva May Offer Way of Detecting and Understanding Early Stages of Parkinson’s, Study Says

July 2019

Parkinsons News Today

Quadrant Biosciences Recognized as New York Technology Business of the Year

May 2019

Market Watch

Study finds correlation between specific epigenetic molecules and autism traits

April 2019

BioSpace

Samsung Spotlights New Digital Health Solutions at HIMSS 2019

February 2019

Samsung Newsroom U.S.

Biomarker panel can detect autism earlier in children using saliva

November 2018

UPI

Saliva-Based RNA Biomarker Test Could Serve as Early Diagnostic Tool for Autism

November 2018

Genetic Engineering & Biotechnology News

Saliva Test Distinguishes Children On Autism Spectrum From Non-Autistic Peers

November 2018

Science Blog

Saliva-based RNA panel distinguishes children on autism spectrum from non-autistic peers

November 2018

EurekAlert

Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers on the Path from Autism Diagnosis to Early Intervention

November 2018

Business Wire

Oral microbial activity may help identify autism in children

August 2018

Healio

Circadian Molecules in Saliva Different in Kids with Sleep Disorders

August 2018

Sleep Review

The Scoop: Tracking MicroRNAs to Study Brain Dysfunction

July 2018

Genetic Engineering & Biotechnology News

THE FATE OF FOOTBALL: Spitting image — new test helps identify concussions

May 2018

NY Daily News

DNA Genotek’s top 10 list for 2017

January 2018

DNA GenoTek

Saliva Test Could Diagnose Concussion

November 2017

WebMD

Spit test may diagnose, predict duration of concussion in kids

November 2017

CNN

Could saliva help diagnose concussions?

May 2017

WRVO

Researchers Discover Novel BioMarker in Saliva that Identifies Concussion in Children and Predicts Length of Recovery

May 2017

Huffington Post

Spit Test May Reveal The Severity Of A Child's Concussion

May 2017

NPR

Press releases

Press releases

Patent Awarded for Saliva-Based Test to Help Diagnose Concussion 
and Predict Duration of Symptoms

November 2022

This is the second patent awarded in less than one year for saliva tests to Quadrant Biosciences and its partners, the State University of New York Research Foundation and the  
Penn State Research Foundation

Quadrant Laboratories Wastewater Testing is Evolving; Serves Most of New York State

September 2022

Quadrant’s wastewater testing is now sequencing COVID-19 positive samples to determine the variant lineages, and more than 76% of New York is participating

Dr. Funda Suer Joins Quadrant Biosciences as EVP of Clinical Diagnostics and CLIA Laboratory Director

May 2022

Suer to expand molecular genetic testing portfolio at Quadrant

Quadrant Biosciences Names TV Journalist Dana Dean as VP of PR

April 2022

Dean will focus on the company’s brand narrative and enhancing its corporate reputation, the company said in a statement. 

Patent Issued for Multiomic Approach to Autism Spectrum Disorder Diagnosis

February 2022

Quadrant Biosciences, SUNY RF and Penn State RF receive patent for novel epigenetic saliva test for autism.

Quadrant Biosciences to Offer Affordable Clarifi COVID-19 Testing to Businesses

September 2021

To help meet the new federal government testing mandate, Quadrant Biosciences is offering affordable COVID testing to businesses throughout NYS. 

Rita Marble Joins Quadrant Biosciences as Executive Vice President of Human Resources

August 2021

Quadrant Biosciences welcomes Rita Marble to their team as Executive Vice President of Human Resources. Rita brings more than 20 years of leadership experience in the field of Human Resources Management to the Quadrant team.

Molecules in Saliva May Hold the Key to Tracking Improvements in Autism

June 2021

Molecules in the saliva may hold promise as a means to track the effectiveness of therapeutic interventions in children with autism spectrum disorder (ASD), according to a recently published study in the journal Research in Autism Spectrum Disorder.

Autism Biomarkers Could Save Billions in Healthcare Costs According to Recent Study

April 2021

The use of accurate biomarkers for detecting autism spectrum disorder (ASD) could result in saving billions of dollars in healthcare costs, according to a paper recently published in the journal Autism Research.

Quadrant Biosciences Receives Breakthrough Device Designation for Novel Autism Saliva Test

April 2021

Quadrant Biosciences has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the FDA for its innovative Clarifi ASD autism saliva test.

Quadrant Biosciences CEO Rich Uhlig named Top 50 Healthcare Technology CEO

April 2021

CEO Richard Uhlig recognized for his exemplary leadership during global pandemic.

Quadrant Biosciences Names New Chief Technology Officer

April 2021

Quadrant Biosciences announced that Nick Gianadda has joined the company as Chief Technology Officer.

Rita Romano to Head Quadrant Biosciences Laboratory Testing Division

February 2021

Quadrant Biosciences Inc., announced that Rita Romano has assumed the role of President of it’s newly created Quadrant Laboratories division.

Quadrant Biosciences and SUNY Upstate Receive MedTech "Project of the Year Award

January 2021

Quadrant Biosciences and SUNY Upstate Medical to receive MedTech’s 2020 Project of the Year award for the development of the Clarifi COVID-19 saliva test.

Saliva may hold key to concussion diagnosis and managment

October 2020

A simple saliva swab may hold the key to diagnosing and managing mild traumatic brain injury (i.e., concussions), according to a study recently published in the journal Clinical and Translational Medicine.

Quadrant Biosciences Receives FDA Emergency Authorization for New COVID-19 Saliva Test

September 2020

New test offers simple, easy to administer saliva swab for COVID-19 testing.

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

September 2020

Quadrant Biosciences said on Monday that it has received a $2.3 million grant from the National Institutes of Health to develop its saliva-based microRNA diagnostic test for concussions in children and adolescents.

Renowned autism researcher Dr. Thomas Frazier joins Quadrant Biosciences Clinical Advisory Board

June 2020

 Dr. Frazier will help guide research and clinical acceptance of the new Clarifi autism saliva test.

Quadrant Biosciences Receives CPT® Proprietary Laboratory Analyses Code from the American Medical Association

April 2020

Quadrant Biosciences Inc (Quadrant Biosciences) announced today that the American Medical Association (AMA) has issued a new CPT® Proprietary Laboratory Analyses (PLA) code for its Clarifi ASD™ autism saliva test.

Company That just Released World’s First Saliva Test for Autism Opens Up Investment Opportunity to the Public

March 2020

Quadrant Biosciences Inc, a leading developer of epigenetic diagnostic solutions, including the world’s first saliva test for autism, announced that it is now offering common shares of the company (at a price of $3/share, with a minimum investment of $300) through equity crowdfunding platform Wefunder.

Quadrant Biosciences Launches First Ever Epigenetic Saliva Test for Autism

December 2019

Quadrant Biosciences Inc., a developer of novel diagnostic solutions, announced the release of Clarifi ASD™, the first ever epigenetic test for autism spectrum disorder (ASD).

New Research shows link between Parkinson's disease and the microbiome

July 2019

A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One.

Quadrant Biosciences Takes Next Step in the Detection of Autism

June 2019

Quadrant Biosciences has been awarded a $330,000 grant from the National Institutes of Health (NIH).

Quadrant Biosciences Recognized as New York Technology Business of the Year

May 2019

Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC).

Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers on the Path from Autism Diagnosis to Early Intervention

November 2018

As part of its commitment to helping people with autism and their families and increasing early intervention through early diagnosis, Quadrant Biosciences announced today that they will support Autism Speaks’ mission with funding to expand delivery of reliable information, resources and support through the Autism Speaks Autism Response Team.

Quadrant Biosciences Partners with Leading Edge Genomic Testing Company Admera Health

August 2018

Quadrant Biosciences Inc., an emerging life science company based in Syracuse, New York, is pleased to announce its strategic partnership with Admera Health, an advanced molecular diagnostics company headquartered in South Plainfield, NJ.

Wall Street Veteran Peter Cohen joins Quadrant Biosciences Board of Directors

April 2018

Quadrant Biosciences Inc., a Syracuse, New York-based Life Science company, announced today that Wall Street veteran Peter Cohen will be joining its Board of Directors.

Motion Intelligence Inc. changes name to Quadrant Biosciences Inc. to Better Reflect Broader Business Focus

June 2017

Motion Intelligence Inc. announced that it has changed its company name to Quadrant Biosciences Inc. The Syracuse, New York-based neuroscience company is involved in the development of functional assessments and epigenetic diagnostic solutions for large-scale health issues.